Miguel Pereira-Silva, PharmD | PhD, PG
@miguel_persilva
Postdoctoral Scientist @MDAndersonNews |@KalluriLab | Pancreatic Cancer Therapies👨🔬🚩Pharmacist💊 Cinephile🎥 Photographer📸 Pianist🎹 Writer📝 Overthinker🧠
ID: 3280645978
https://scholar.google.com/citations?user=nUdzv0oAAAAJ&hl=pt-PThttps://orcid.org/0000-0003-4276-5063 17-05-2015 19:46:58
1,1K Tweet
1,1K Followers
5,5K Following
🎉🎈🪅 I am pleased to share our new experimental article on #biomimetic partially-disguised 🥸 #micelle-like #cancer #cellmembrane #nanoparticles 🪅 for #pancreaticcancer therapies 🚀! #DrugDelivery iMATUS (Instituto de Materiales de la USC) #FFUC #FFUSC 🛰️⛳ #openaccess 🔓🌐 tandfonline.com/doi/full/10.10…
Interested in cancer cell membrane-coated nanoparticles? Preparation and characterization by Miguel Pereira-Silva, PharmD | PhD, PG with collaborators from Universidade de Coimbra and Carmen Alvarez-Lorenzo Bárbara Blanco-Fernandez Luis Diaz Gomez Angel Concheiro Nine Instituto de Invest. Sanitaria de Santiago (IDIS) Agencia Estatal de Investigación Axencia Galega de Innovación iMATUS (Instituto de Materiales de la USC) Open Access 👇
Kick-off of the Symposium "A Decade of Advances in #PancreaticCancer Researcher & Clinical Care" by Professor Raghu Kalluri MD Anderson Cancer Center Kalluri Lab
A huge honor to have met Professor Anirban Maitra Anirban Maitra in person!! A moment I had been anticipating since 2018 🌟 #pancreaticcancer #cancerresearch #cancer!
The largest #wildfire in the history of Portugal moves now violently - and "unstoppable" - to Serra da Estrela' highest peak, Torre (highest point in mainland Portugal). +60.000ha, +150.000 acres scorched. Unbelievable. VOST Portugal
🌟Honored - and humbled - to have received the EDA Julia Polak Award🎖️2025 at the European Society for Biomaterials 🔬#ESB Congress in Turin, Italy. Grateful to all supervisors, mentors, colleagues, and family for their support #idfarma Carmen Alvarez-Lorenzo Universidade de Coimbra #USC
🎉 It’s Official! Our phase 1️⃣ trial of iExosomes in metastatic pancreatic cancer is now published in Nature Communications Zero DLTs in this first-in-human trial of systemically administered engineered exosomes targeting KRAS G12D ‼️ Phase 2️⃣ is underway! nature.com/articles/s4146…
📣Our latest review of cancer-associated fibroblasts as therapeutic targets for cancer control. A deep dive by Viktoria Böker, we summarize challenges, opportunities, clinical trials, and new developments‼️ Check it out in Cell Reports Medicine ⬇️ cell.com/cell-reports-m…